Harry Glorikian, Author of The Future You.

The Health Design Podcast

Harry Glorikian is a global business expert, healthcare entrepreneur, podcaster and author of The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer (Brick Tower Press, Oct. 2021). For over three decades, Glorikian has built a breadth of successful ventures in the healthcare space, and he is well known for being at the forefront of helping invest in and grow innovative healthcare companies that are tackling ground-breaking areas of healthcare and biotechnology. A sought-after speaker, Glorikian is frequently quoted in the media and regularly asked to assess, influence, and be part of innovative concepts and trends. He also holds four US patents in telecommunications and has others pending. Glorikian currently serves as a General Partner at Scientia Ventures , a VC firm focused on upleveling companies that have the potential to transform healthcare. In particular, the firm targets businesses at the cutting edge of life sciences with an emphasis on computational biology and chemistry, the digitization of medicine and digital therapies. Additionally, Glorikian serves on the boards of StageZero Life Sciences (TSX: SZLS), a publicly traded healthcare technology business dedicated to the early detection of cancer and multiple disease states through whole blood, and Drumroll Health, which develops AI technologies to foster closer partnerships between patients, healthcare professionals and healthcare companies. In his newest release, The Future You: How Artificial Intelligence Can Help You Get Healthier, Stress Less, and Live Longer (Brick Tower Press, Oct. 2021), Glorikian brings his learnings to the general consumer who wants to understand how all this new technology and talk of artificial intelligence can make their lives and those of their family and friends more fulfilling through better health. Glorikian walks through how readers can shape the best and healthiest version of themselves and how artificial intelligence (AI) can be a powerful tool on that journey. Before joining Scientia Ventures, Glorikian was an entrepreneur. He grew and sold his own healthcare consulting company, Scientia Advisors, which served some of the global technology and healthcare companies in the world, many of which were on the Global 500 and Fortune 500. Glorikian also served as an Entrepreneur-In-Residence to GE Ventures – New Business Creation Group, leading to the founding of Evidation Health and DrawBridge Health. He is the author of MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market and the diagnostics textbook Commercializing Novel IVDs: A Comprehensive Manual for Success, and is the host of The Harry Glorikian Show podcast series. Glorikian holds an MBA from Boston University and a bachelor’s degree from San Francisco State University. Harry has addressed the National Institutes of Health, Molecular Medicine Tri-Conference, World Theranostics Congress, and other audiences, worldwide. Visit https://glorikian.com/ for more information.